Prostate cancer decisions — 2022
1,116 indexed Board decisions in 2022.
Badges describe the whole decision, not the outcome for every condition listed. An appeal can grant one issue and deny or remand another. Check the original decision for each issue; these outcomes do not predict your claim.
- Whole decision: GrantedOctober 2022
The Veteran's claim for service connection for residuals of prostate cancer is granted due to the presumption of exposure to herbicide agents, as his duties placed him in close proximity to the DMZ during his service in Korea.
- Whole decision: GrantedOctober 2022
The Veteran's prostate cancer residuals have required changing absorbent material more than 4 times per day, qualifying for a 60 percent rating.
- Whole decision: GrantedOctober 2022
The Veteran's claim for service connection of prostate cancer is granted with an effective date of August 21, 2015.
- Whole decision: DeniedOctober 2022
The Veteran's claims for service connection for prostate cancer, erectile dysfunction as secondary to prostate cancer, and urinary frequency as secondary to prostate cancer have been denied. The Board found no evidence of herbicide exposure during service, and the Veteran does not meet the criteria for presumptive service connection due to his Vietnam-era service. Additionally, there is insufficient evidence to establish a link between the current conditions and service.
- Whole decision: GrantedOctober 2022
The Veteran's service-connected prostate cancer is linked to his current voiding residuals, erectile dysfunction, and unspecified anxiety disorder. The PACT Act of 2022 grants service connection for these conditions.
- Whole decision: Remanded (sent back)October 2022
The Board has decided to remand the cases for further development and consideration due to potential additional residuals of prostate cancer not fully addressed by previous examinations.
- Whole decision: GrantedOctober 2022
The Veteran's service connection claims for prostate cancer, diabetes mellitus, and hypertension are granted. The Board has remanded the cases to determine if there is a causal relationship between these conditions and exposure to ionizing radiation during service.
- Whole decision: Remanded (sent back)October 2022
The Board has remanded the Veteran's appeal for further development, including a VA examination by a urologist to differentiate between symptoms attributable to each of his service-connected genitourinary disabilities.
- Whole decision: Partly grantedOctober 2022
The Veteran's claims for service connection for achalasia, prostate cancer, and bilateral hearing loss are denied. The case is remanded for further action on the issue of bilateral hearing loss.
- Whole decision: GrantedPACT Act · October 2022
The Veteran's prostate cancer, erectile dysfunction, and voiding dysfunction are granted as secondary to exposure to herbicide agents. The Veteran's GERD is remanded for further examination.
- Whole decision: Remanded (sent back)October 2022
The Veteran's prostate condition, including prostate cancer, prostatitis, and benign prostatic hyperplasia, is remanded for further examination and opinion regarding the relationship to service, particularly exposure to Agent Orange.
- Whole decision: GrantedOctober 2022
The Veteran's service connection claims for coronary heart disease, prostate cancer, and bladder cancer are granted as these conditions are presumed related to herbicide exposure during his active military service in Thailand.
- Whole decision: GrantedOctober 2022
The Veteran's service-connected disabilities render him unable to secure and follow a substantially gainful occupation, warranting a TDIU based on PTSD and prostate cancer.
- Whole decision: GrantedOctober 2022
The Board has granted service connection for prostate cancer, coronary atherosclerosis and paroxysmal atrial fibrillation, diabetes mellitus type II, and erectile dysfunction due to in-service exposure to herbicide agents. Bone cancer is denied as there was no diagnosis of multiple myeloma or other presumptively service-connected condition.
- Whole decision: GrantedPACT Act · October 2022
The Veteran's prostate cancer is granted service connection as presumptively linked to herbicide exposure during his service at U-Tapao Royal Thai Air Force Base in Thailand.
- Whole decision: GrantedPACT Act · October 2022
The Veteran's bladder and prostate cancers are granted service connection due to exposure to herbicide agents during his time in Thailand, as provided by the PACT Act of 2022.
- Whole decision: DeniedOctober 2022
The Veteran's cause of death, adult failure to thrive due to or as a consequence of prostate cancer, was not service-connected. The Board found no evidence linking the conditions to his military service.
- Whole decision: DeniedOctober 2022
The Board denied the Veteran's request for an earlier effective date for service connection of prostate cancer and diabetes mellitus, type II. The decision on prostate cancer was based on March 27, 2020 as the date VA received the intent to file a claim, which was followed up within one year with a formalized claim.
- Whole decision: Remanded (sent back)October 2022
The Veteran's claims for service connection are remanded due to incomplete records, particularly regarding his periods of active duty and inactive duty training. The Board requires additional development to account for any missing records.
- Whole decision: DeniedOctober 2022
The Veteran's death was not caused by a service-connected disability, and the cause of death (malignant neoplasm of bladder) is not related to his military service.
← Back to Prostate cancer overview
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.